On this account, a new biomarker, the fibrinogen to albumin ratio, was implemented to determine medical conditions including malnutrition, coagulation system, systemic inflammation, and hepatic insufficiency [20,21,22,23,24,25,26]. This evidence concerns the gene ALB and nutritional deficiency disease.